Profiling genetic variants in cardiovascular disease genes among a Heterogeneous cohort of Mendelian conditions patients and electronic health records.

United Arab Emirates population electronic health records genes heritable cardiovascular disease mendelian study cohort signalling pathways variants

Journal

Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173

Informations de publication

Date de publication:
2024
Historique:
received: 21 06 2024
accepted: 09 09 2024
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

This study addresses the rising cardiovascular disease (CVD) rates in the United Arab Emirates (UAE) by investigating the occurrence and impact of genetic variants in CVD-related genes. We collected all genes linked to heritable CVD from public and diagnostic databases and mapped them to their corresponding biological processes and molecular pathways. We then evaluated the types and burden of genetic variants within these genes in 343 individuals from the Emirati Mendelian Study Cohort and 3,007 national electronic health records. We identified a total of 735 genes associated with heritable CVD, covering a range of cardiovascular conditions. Enrichment analysis revealed key biological processes and pathways, including Apelin, FoxO, and Ras signaling, that are implicated across all forms of heritable CVD. Analysis of a UAE cohort of 3,350 individuals showed a predominance of rare and unique CVD variants specific to the population. The study found a significant burden of pathogenic variants in families with CVD within the Emirati Mendelian cohort and re-assessed the pathogenicity of 693 variants from national health records, leading to the discovery of new CVD-causing variants. This study underscores the importance of continuously updating our understanding of genes and pathways related to CVD. It also highlights the significant underrepresentation of the UAE population in public databases and clinical literature on CVD genetics, offering valuable insights that can inform future research and intervention strategies.

Identifiants

pubmed: 39411402
doi: 10.3389/fmolb.2024.1451457
pii: 1451457
pmc: PMC11473968
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1451457

Informations de copyright

Copyright © 2024 Akawi, Al Mansoori, Al Zaabi, Badics, Al Dhaheri, Al Shamsi, Al Tenaiji, Alzohily, Almesmari, Al Hammadi, Al Dhahouri, Irshaid, Kizhakkedath, Al Shibli, Tabouni, Allam, Baydoun, Alblooshi, Ali, Foo and Al Jasmi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Nadia Akawi (N)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Division of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom.

Ghadeera Al Mansoori (G)

Department of Cardiology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.

Anwar Al Zaabi (A)

Department of Cardiology, Tawam Hospital, Al Ain, United Arab Emirates.

Andrea Badics (A)

Department of Cardiology, Tawam Hospital, Al Ain, United Arab Emirates.

Noura Al Dhaheri (N)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Genetic Metabolic Division, Pediatrics Department, Tawam Hospital, Al Ain, United Arab Emirates.

Aisha Al Shamsi (A)

Genetic Metabolic Division, Pediatrics Department, Tawam Hospital, Al Ain, United Arab Emirates.

Amal Al Tenaiji (A)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Department of Pediatrics, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.

Bashar Alzohily (B)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Fatmah S A Almesmari (FSA)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Hamad Al Hammadi (H)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Nahid Al Dhahouri (N)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Manal Irshaid (M)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Praseetha Kizhakkedath (P)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Fatema Al Shibli (F)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Mohammed Tabouni (M)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Mushal Allam (M)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Antimicrobial Research Unit, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

Ibrahim Baydoun (I)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Hiba Alblooshi (H)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Bassam R Ali (BR)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Roger S Foo (RS)

Cardiovascular Research Institute, Centre for Translational Medicine, National University Health System, Singapore, Singapore.
Genome Institute of Singapore, and Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.

Fatma Al Jasmi (F)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Classifications MeSH